Sabrina Paganoni, MD, PhD of Massachusetts General Hospital was joined by guest speakers Xiaowei (Bill) Su, MD, PhD and Michael Robinson, MD to discuss ALS research from bench to bedside. Dr. Su presented an overview of the drug development process in ALS research, and Dr. Robinson provided insight into the regulatory process when a new drug application is submitted to the Food and Drug Administration (FDA).

Visit the Mass General website to register for future webinars: https://www.massgeneral.org/neurology...

Sign up for the ALS Link to stay up to date about the HEALEY ALS Platform Trial and ALS research: https://lp.constantcontactpages.com/s...

Follow MGH Neurology on Facebook (  / mghneurology  ) and Twitter (  / mghneurology  )